{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:33:27Z","timestamp":1790897607730,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.atherosclerosis.2009.11.005","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:19:16Z","timestamp":1258003156000},"page":"274-277","source":"Crossref","is-referenced-by-count":64,"title":["An imbalanced OPG\/TRAIL ratio is associated to severe acute myocardial infarction"],"prefix":"10.1016","volume":"210","author":[{"given":"Paola","family":"Secchiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Corallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Paolo","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ceconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bonasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Zauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cytogfr.2006.04.002","article-title":"The role of the TRAIL\/TRAIL-receptors system in hematopoiesis and endothelial cell biology","volume":"17","author":"Zauli","year":"2006","journal-title":"Cyt Growth Fact Rev"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib3","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib4","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.2353\/ajpath.2006.060398","article-title":"An increased osteoprotegerin (OPG) serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction","volume":"169","author":"Secchiero","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.atherosclerosis.2008.10.024","article-title":"Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women","volume":"204","author":"Shargorodsky","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2005.10.028","article-title":"Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis","volume":"184","author":"Schoppet","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehp004","article-title":"Prognostic value of apoptosis markers in advanced heart failure patients","volume":"30","author":"Niessner","year":"2009","journal-title":"Eur Heart J"},{"issue":"June","key":"10.1016\/j.atherosclerosis.2009.11.005_bib9","article-title":"Soluble TRAIL prevents RANTES-dependent restenosis after percutaneous coronary intervention in patients with coronary artery disease","author":"Satoh","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/01.RES.0000067928.83455.9C","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially up-regulates nitric oxide and prostanoid production in primary human endothelial cells","volume":"92","author":"Zauli","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib11","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2004-10-4111","article-title":"TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release","volume":"105","author":"Secchiero","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.106.643841","article-title":"Systemic TRAIL delivery shows anti-atherosclerotic activity in apoE-null diabetic mice","volume":"114","author":"Secchiero","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib13","first-page":"741","article-title":"Guidelines for the diagnosis of heart failure: the Task Force on Heart Failure of the European Society of Cardiology","volume":"16","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib14","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","article-title":"Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE\u2212\/\u2212 mice","volume":"26","author":"Bennett","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.11.005_bib15","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/ATVBAHA.109.188185","article-title":"Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice","volume":"29","author":"Ovchinnikova","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009009265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009009265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T13:23:13Z","timestamp":1544880193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009009265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0021915009009265"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.11.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}